
Richard G. Hutson
Examiner (ID: 18331)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1576 |
| Issued Applications | 843 |
| Pending Applications | 212 |
| Abandoned Applications | 563 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19060396
[patent_doc_number] => 11939606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => CRISPR-associated (Cas) protein
[patent_app_type] => utility
[patent_app_number] => 17/678369
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 24186
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678369 | CRISPR-associated (Cas) protein | Feb 22, 2022 | Issued |
Array
(
[id] => 18701583
[patent_doc_number] => 11788082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => T4 DNA ligase variants with increased thermostability
[patent_app_type] => utility
[patent_app_number] => 17/677655
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8667
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677655 | T4 DNA ligase variants with increased thermostability | Feb 21, 2022 | Issued |
Array
(
[id] => 18583162
[patent_doc_number] => 20230265421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => TYPE II CRISPR/CAS9 GENOME EDITING SYSTEM AND THE APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/676546
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676546 | Type II CRISPR/Cas9 genome editing system and the application thereof | Feb 20, 2022 | Issued |
Array
(
[id] => 18461629
[patent_doc_number] => 11685913
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-27
[patent_title] => T4 DNA ligase variants with increased resistance to salt
[patent_app_type] => utility
[patent_app_number] => 17/675278
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8075
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675278 | T4 DNA ligase variants with increased resistance to salt | Feb 17, 2022 | Issued |
Array
(
[id] => 17642334
[patent_doc_number] => 20220170072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PROGRAMMABLE DNA-GUIDED ARTIFICIAL RESTRICTION ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/673279
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673279 | PROGRAMMABLE DNA-GUIDED ARTIFICIAL RESTRICTION ENZYMES | Feb 15, 2022 | Abandoned |
Array
(
[id] => 19441457
[patent_doc_number] => 12091699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Method for enhancing production of homeoprotein using inhibitor of lysosomal function
[patent_app_type] => utility
[patent_app_number] => 17/586234
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5274
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586234 | Method for enhancing production of homeoprotein using inhibitor of lysosomal function | Jan 26, 2022 | Issued |
Array
(
[id] => 18996205
[patent_doc_number] => 11913038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Engineered polymerases for improved sequencing
[patent_app_type] => utility
[patent_app_number] => 17/564500
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 24922
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/564500 | Engineered polymerases for improved sequencing | Dec 28, 2021 | Issued |
Array
(
[id] => 18916883
[patent_doc_number] => 11879154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Preparation method of high-stability superoxide dismutase with transmembrane capability
[patent_app_type] => utility
[patent_app_number] => 17/563794
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 4970
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563794 | Preparation method of high-stability superoxide dismutase with transmembrane capability | Dec 27, 2021 | Issued |
Array
(
[id] => 18988089
[patent_doc_number] => 20240060058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Modified DNA Polymerase
[patent_app_type] => utility
[patent_app_number] => 18/259225
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259225
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259225 | Modified DNA Polymerase | Dec 23, 2021 | Pending |
Array
(
[id] => 18987890
[patent_doc_number] => 20240059859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL PROTEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/270248
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270248 | NOVEL PROTEASES AND USES THEREOF | Dec 20, 2021 | Pending |
Array
(
[id] => 18987890
[patent_doc_number] => 20240059859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL PROTEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/270248
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270248 | NOVEL PROTEASES AND USES THEREOF | Dec 20, 2021 | Pending |
Array
(
[id] => 17627558
[patent_doc_number] => 20220162573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => POLYMERASE COMPOSITIONS, METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/645146
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/645146 | Polymerase compositions, methods of making and using same | Dec 19, 2021 | Issued |
Array
(
[id] => 17533925
[patent_doc_number] => 20220112534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Compositions and Methods Related to Nucleic Acid Synthesis
[patent_app_type] => utility
[patent_app_number] => 17/554012
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554012 | Compositions and methods related to nucleic acid synthesis | Dec 16, 2021 | Issued |
Array
(
[id] => 17520726
[patent_doc_number] => 20220106575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => KETOREDUCTASE POLYPEPTIDES FOR THE SYNTHESIS OF CHIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/553455
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553455 | Ketoreductase polypeptides for the synthesis of chiral compounds | Dec 15, 2021 | Issued |
Array
(
[id] => 17520726
[patent_doc_number] => 20220106575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => KETOREDUCTASE POLYPEPTIDES FOR THE SYNTHESIS OF CHIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/553455
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553455 | Ketoreductase polypeptides for the synthesis of chiral compounds | Dec 15, 2021 | Issued |
Array
(
[id] => 19034457
[patent_doc_number] => 20240084272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/266787
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266787 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | Dec 9, 2021 | Pending |
Array
(
[id] => 19034457
[patent_doc_number] => 20240084272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/266787
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266787 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | Dec 9, 2021 | Pending |
Array
(
[id] => 17627642
[patent_doc_number] => 20220162657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => GLUCOAMYLASES AND METHODS OF USE, THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/544668
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544668 | GLUCOAMYLASES AND METHODS OF USE, THEREOF | Dec 6, 2021 | Abandoned |
Array
(
[id] => 18923328
[patent_doc_number] => 20240026332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => LIQUID ENZYME PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/255349
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255349 | LIQUID ENZYME PREPARATION | Dec 1, 2021 | Pending |
Array
(
[id] => 18923328
[patent_doc_number] => 20240026332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => LIQUID ENZYME PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/255349
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255349 | LIQUID ENZYME PREPARATION | Dec 1, 2021 | Pending |